Expanding its reputation as a global hub for the final dose supply chain is a key strategy for CPhI in 2016
CPhI Worldwide, organised by UBM EMEA, is to launch a new co-located event entirely dedicated to Finished Dosage Formulation (FDF). This new event will open at the 27th CPhI Worldwide in Barcelona (4-6 October 2016) and reflects the huge growth in finished dosage formulations across the wider pharma market.
FDF will gather together the entire supply chain in one location at CPhI WW, from Big Pharma and CMOs, to out-licensing and dossier specialists, end product distributors, generic pharma companies, and home markets. It will act as a global meeting-point for any company looking to grow, launch or distribute finished formulations in international or national markets, UBM says.
Over the last few years, sales in the pharmaceutical supply chain have accelerated across commercial supply and final dosage forms, where more complex solutions and higher margin products are common. Pharma companies seeking partners with new formulations, and the rise in complex and difficult to formulate compounds are driving the growth in this market.
Additionally, CPhI stated, generics and the increasing use of out-licensed formulations are a key factor behind its decision. In fact, since the introduction of the FDF zone at CPhI Worldwide in 2011, it has quickly grown to be the third largest part of the show totalling in excess of 11,000m2 in 2015.
Dosage forms represented will cover all types of solid dose, semi-solids, liquids, sprays and steriles from both pharma and biologics companies, including tablets, capsules, gels, parenteral drugs, vials, patches, creams, inhalation, nasal, sublingual and suppository.
'Finished dose formulations are already a huge part of CPhI Worldwide. And, both within the wider market and in terms of exhibitor numbers, it is one of the fastest growing areas in pharma,' said Rutger Oudejans, Brand Director Pharma at UBM EMEA. 'Our aim in 2016 is to cement FDF’s reputation as the essential platform for launching and conducting business in the global finished dose market.'
FDF will be supported by its own dedicated content, and a more prescriptive 1-2-1 matchmaking platform, which will enable professionals within this supply chain to explore the latest developments, strategies and market analysis. Topics will include everything from regulatory approvals, processes and changes, to key growth markets, new formulation technologies, distribution and commercialisation.
Cara Turner, Event Manager at UBM EMEA for FDF, added: 'While a number of our attendees do indeed work across both API and commercialised products, we took the decision to dedicate a co-located event to those looking to concentrate on finished product supply. In practical terms, this means we have created new content, sessions, networking and the best new business opportunities in one place. This way our attendees and exhibitors can more quickly identify leads through our company matchmaking platform and move between potential clients and customers.
'By launching FDF, we are creating the ideal set of conditions for exploring this thriving sector. So beyond the customers and potential clients attendees arrange meetings with, there is undoubtedly a wealth of further opportunities available from just exploring this part of the exhibition floor.'